ABLD — AbL Diagnostics SA Balance Sheet
0.000.00%
- €86.91m
- €88.93m
- €5.33m
Annual balance sheet for AbL Diagnostics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 2.36 | 2.7 | 1.03 | 2.23 | 0.529 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.015 | 0.011 | 4.93 | 4.31 | 3.45 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2.38 | 2.71 | 12 | 11.6 | 8.43 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.002 | 0 | 0.827 | 0.511 | 0.463 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2.38 | 2.71 | 15.4 | 14.9 | 11.8 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.018 | 0.094 | 6.99 | 5.84 | 2.8 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.018 | 0.094 | 8.65 | 8.14 | 4.32 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2.36 | 2.62 | 6.75 | 6.77 | 7.49 |
Total Liabilities & Shareholders' Equity | 2.38 | 2.71 | 15.4 | 14.9 | 11.8 |
Total Common Shares Outstanding |